Patents by Inventor Klaus Balschat

Klaus Balschat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11925742
    Abstract: A device includes a processor and a non-transitory memory having processor-executable instructions stored thereon. The device is usable with a blood treatment apparatus, such as a hemodialysis machine. The processor-executable instructions, when executed by the processor, facilitate: determining a time point with regard to puncturing a vessel of a patient, wherein puncturing the vessel of the patient is related to a blood treatment for the patient using a blood treatment apparatus; determining a time period based on the determined time point; and transmitting data related to the determined time point and/or data related to the determined time period to a receiving device.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: March 12, 2024
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Stefan Wegner, Reiner Spickermann, Klaus Balschat
  • Publication number: 20210316059
    Abstract: A device includes a processor and a non-transitory memory having processor-executable instructions stored thereon. The device is usable with a blood treatment apparatus, such as a hemodialysis machine. The processor-executable instructions, when executed by the processor, facilitate: determining a time point with regard to puncturing a vessel of a patient, wherein puncturing the vessel of the patient is related to a blood treatment for the patient using a blood treatment apparatus; determining a time period based on the determined time point; and transmitting data related to the determined time point and/or data related to the determined time period to a receiving device.
    Type: Application
    Filed: February 10, 2021
    Publication date: October 14, 2021
    Inventors: Stefan Wegner, Reiner Spickermann, Klaus Balschat
  • Patent number: 10603420
    Abstract: A blood treatment device includes a heat exchanger having a first space and a second space, with a first fluid flowing through the first space and a second fluid flowing through the second space. The heat exchanger has a membrane which separates the first space from the second space, with the membrane forming a component of a capacitor having two capacitor plates, between which the membrane is located. A monitoring means is connected to the capacitor, and is configured to detect an electrical property of the capacitor, for the purpose of detecting a fluid leak from the first space to the second space.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: March 31, 2020
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Reiner Spickermann, Klaus Balschat, Tilman Staeblein, Arne Peters, Peter Kloeffel
  • Publication number: 20180207343
    Abstract: The present invention relates to a blood treatment device having a heat exchanger which has a first space and a second space, wherein the first space is flowed through by a first fluid and the second space is flowed through by a second fluid, and wherein the heat exchanger has a membrane which separates the first space from the second space, wherein the membrane forms a component of a capacitor which has two capacitor plates between which the membrane is located, and wherein monitoring means are provided which are connected to the capacitor and which are configured such that they detect an electrical property of the capacitor for the purpose of detecting a leak from the first space to the second space.
    Type: Application
    Filed: May 19, 2016
    Publication date: July 26, 2018
    Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Reiner SPICKERMANN, Klaus BALSCHAT, Tilman STAEBLEIN, Arne PETERS, Peter KLOEFFEL
  • Patent number: 9782528
    Abstract: A container for dialysis concentrates, in particular acidic dry concentrates, has integral supporting elements. When these dry concentrates are dissolved directly by a dialysis machine to form liquid concentrates, the container must provide a volume of 4-12 liters. To impart the required stability to the container, the container includes the integral supporting elements, which manifest their supporting function only when the container is used on the dialysis machine.
    Type: Grant
    Filed: June 3, 2013
    Date of Patent: October 10, 2017
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Klaus Balschat, Alfred Gagel, Dirk Huemmer, Peter Kloeffel, Olaf Nicholas, Tilman Staeblein
  • Patent number: 9511182
    Abstract: The present invention relates to a medical treatment arrangement having at least three device parts, with the first device part being a device part which is not made for the treatment of a patient, with the second device part being made in conjunction with the third device part such that a treatment of a patient can be made with them, with the second device part being made movable relative to the first device part and relative to the third device part, and with provision furthermore being made that the first device part and the second device part and/or the second device part and the third device part being made such that energy and/or data can be unidirectionally or bidirectionally exchanged between them.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: December 6, 2016
    Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
    Inventors: Klaus Balschat, Berthold Breitkopf, Klaus Sauer, Marcus Hartmann, Dejan Nikolic, Alexander Heide
  • Patent number: 8676512
    Abstract: A method and device are provided for determining the transmembrane pressure during an extracorporeal blood treatment in which blood flows at a defined blood flow rate through an arterial blood conduit of an extracorporeal blood circuit into the inlet of a first chamber of a dialyzer, which is divided by a semipermeable membrane into the first chamber and a second chamber, and flows through a venous blood conduit from the outlet of the first chamber of the dialyzer, while dialysis liquid flows through a dialysis liquid supply conduit into the inlet of the second chamber of the dialyzer and flows through a dialaysis liquid discharge conduit from the outlet of the second chamber of the dialyzer.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: March 18, 2014
    Assignee: Fresenius Medical Care Deutchland GmbH
    Inventors: Klaus Balschat, Alfred Gagel, Michael Kulz, Reiner Spickermann
  • Publication number: 20130333795
    Abstract: The invention relates to a container for dialysis concentrates, in particular acidic dry concentrates. When these dry concentrates are dissolved directly by the dialysis machine to form liquid concentrates, the containers must provide a volume of 4-12 liters. To impart the required stability to these containers, they have integral supporting elements, which manifest their supporting function only when the container is used on the dialysis machine.
    Type: Application
    Filed: June 3, 2013
    Publication date: December 19, 2013
    Inventors: Klaus BALSCHAT, Alfred GAGEL, Dirk HUEMMER, Peter KLOEFFEL, Olaf NICHOLAS, Tilman STAEBLEIN
  • Patent number: 8518258
    Abstract: A hemodialysis machine or hemodiafiltration machine is provided that may be used directly for sampling for the connection to a hemodialyzer or for providing replacement fluid, as is required for regular microbiological testing. The machine does not require any additional components or any complex hygiene measures to prevent secondary contamination. By connecting an inventive sterile sampling set, samples can easily be taken. Closing elements and pumping mechanisms are controlled by a control unit as part of a sampling control program.
    Type: Grant
    Filed: October 22, 2007
    Date of Patent: August 27, 2013
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Klaus Balschat, Reiner Spickermann, Josef Winter
  • Publication number: 20130062265
    Abstract: The present invention relates to a medical treatment arrangement having at least three device parts, with the first device part being a device part which is not made for the treatment of a patient, with the second device part being made in conjunction with the third device part such that a treatment of a patient can be made with them, with the second device part being made movable relative to the first device part and relative to the third device part, and with provision furthermore being made that the first device part and the second device part and/or the second device part and the third device part being made such that energy and/or data can be unidirectionally or bidirectionally exchanged between them.
    Type: Application
    Filed: May 20, 2011
    Publication date: March 14, 2013
    Inventors: Klaus Balschat, Berthold Breitkopf, Klaus Sauer, Marcus Hartmann, Dejan Nikolic, Alexander Heide
  • Patent number: 8315654
    Abstract: The present invention relates to an extracorporeal blood treatment device comprising a treatment unit and a device for controlling the treatment unit for preparing and carrying out the blood treatment. The blood treatment device also comprises an internal communication unit for communicating with an external communication unit. In order to the prepare the device blood treatment, the patient sends an initiation code by means of an external communication unit to the internal communication device. Routines required for preparing the blood treatment are then started. One main advantage is that the patient, for example during home dialysis, does not need to be present when the device is preparing for dialysis and the dialysis preparation can be started when the patient thinks of returning home in time for the beginning of the preparation phase.
    Type: Grant
    Filed: August 22, 2007
    Date of Patent: November 20, 2012
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Klaus Balschat, Pascal Kopperschmidt, Reiner Spickermann
  • Patent number: 8104348
    Abstract: The present invention relates to a method and a device for monitoring a flowing medium, in particular the blood flowing in an extracorporeal blood circulation, for the presence of air, in particular micro-bubbles. A sequence of signal pulses or a continuous signal is injected into the flowing medium, and the signal pulses or continuous signal leaving the flowing medium are received. To detect micro-bubbles, a signal pattern that is characteristic of the variation over time of the received signal pulses or the continuous signal in a predetermined period of time is extracted from the signal received. The characteristic signal pattern is compared with one or more characteristic reference patterns, and the presence of air bubbles is determined if the characteristic signal pattern deviates from the characteristic reference pattern by a predetermined amount. Statistical characteristic variables, in particular the variance, are preferably determined from the signal patterns and compared with one another.
    Type: Grant
    Filed: April 15, 2006
    Date of Patent: January 31, 2012
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Klaus Balschat, Tobias Fritsche, Alfred Gagel, Steffen Kirchner, Hans-Joachim Muench, Olaf Nicholas, Jochen Schneider, Reiner Spickermann, Santer Zur Host-Meyer
  • Publication number: 20100323724
    Abstract: The present invention relates to an extracorporeal blood treatment device comprising a treatment unit and a device for controlling the treatment unit for preparing and carrying out the blood treatment. The blood treatment device also comprises an internal communication unit for communicating with an external communication unit. In order to the prepare the device blood treatment, the patient sends an initiation code by means of an external communication unit to the internal communication device. Routines required for preparing the blood treatment are then started. One main advantage is that the patient, for example during home dialysis, does not need to be present when the device is preparing for dialysis and the dialysis preparation can be started when the patient thinks of returning home in time for the beginning of the preparation phase.
    Type: Application
    Filed: August 22, 2007
    Publication date: December 23, 2010
    Inventors: Klaus Balschat, Pascal Kopperschmidt, Reiner Spickermann
  • Publication number: 20100280761
    Abstract: A method and device are provided for determining the transmembrane pressure during an extracorporeal blood treatment in which blood flows at a defined blood flow rate through an arterial blood conduit of an extracorporeal blood circuit into the inlet of a first chamber of a dialyzer, which is divided by a semipermeable membrane into the first chamber and a second chamber, and flows through a venous blood conduit from the outlet of the first chamber of the dialyzer, while dialysis liquid flows through a dialysis liquid supply conduit into the inlet of the second chamber of the dialyzer and flows through a dialaysis liquid discharge conduit from the outlet of the second chamber of the dialyzer.
    Type: Application
    Filed: December 17, 2008
    Publication date: November 4, 2010
    Inventors: Klaus Balschat, Alfred Gagel, Michael Külz, Rainer Spickermann
  • Publication number: 20100130906
    Abstract: The invention relates to the field of equipment for renal replacement therapy. It is based on the observation that connections (14, 15, 101) already present in a hemodialysis machine or hemodiafiltration machine (10) may also be used directly for sampling for the connection to a hemodialyzer or for providing replacement fluid, as is required for regular microbiological testing. The invention does not require any additional components on the equipment or any complex hygiene measures to prevent secondary contamination. By connecting an inventive sterile sampling set, samples can easily be taken. On the equipment end, one need only to program the control unit (26) to implement the inventive method by means of corresponding control of the closing means (20, 21, 103) and the pumping mechanisms (17, 18) as part of a sampling control program.
    Type: Application
    Filed: October 22, 2007
    Publication date: May 27, 2010
    Inventors: Klaus Balschat, Reiner Spickermann
  • Publication number: 20090205426
    Abstract: The present invention relates to a method and a device for monitoring a flowing medium, in particular the blood flowing in an extracorporeal blood circulation, for the presence of air, in particular micro-bubbles. A sequence of signal pulses or a continuous signal is injected into the flowing medium, and the signal pulses or continuous signal leaving the flowing medium are received. To detect micro-bubbles, a signal pattern that is characteristic of the variation over time of the received signal pulses or the continuous signal in a predetermined period of time is extracted from the signal received. The characteristic signal pattern is compared with one or more characteristic reference patterns, and the presence of air bubbles is determined if the characteristic signal pattern deviates from the characteristic reference pattern by a predetermined amount. Statistical characteristic variables, in particular the variance, are preferably determined from the signal patterns and compared with one another.
    Type: Application
    Filed: April 15, 2006
    Publication date: August 20, 2009
    Inventors: Klaus Balschat, Tobias Fritsche, Alfred Gagel, Steffen Kirchner, Hans-Joachim Muench, Olaf Nicholas, Jochen Schneider, Reiner Spickermann, Santer Zur Host-Meyer
  • Patent number: 6804991
    Abstract: In order to detect a leakage in a fluid system of a blood treatment apparatus having an extracorporeal blood circuit, the pressure in the fluid system is measured continuously during a predetermined period of the duration of treatment, and the leak rates are calculated from the change in the pressure at predetermined time intervals of the predetermined period of the duration of treatment. The leakage volume in the predetermined period of the duration of treatment is calculated from the leak rates, and the leakage volume is compared with a predetermined limit value. If the leakage volume is greater than the limit value, this indicates a possible loss of leaktightness in the system. This can be verified with a conventional pressure-holding test. The method and device are characterized by the fact that it is not necessary in principle to interrupt the blood treatment in order to detect a loss of leaktightness.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: October 19, 2004
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Klaus Balschat, Helmuth Ender, Alfred Gagel, Reiner Spickermann
  • Publication number: 20030136181
    Abstract: In order to detect a leakage in a fluid system of a blood treatment apparatus having an extracorporeal blood circuit, the pressure in the fluid system is measured continuously during a predetermined period of the duration of treatment, and the leak rates are calculated from the change in the pressure at predetermined time intervals of the predetermined period of the duration of treatment. The leakage volume in the predetermined period of the duration of treatment is calculated from the leak rates, and the leakage volume is compared with a predetermined limit value. If the leakage volume is greater than the limit value, this indicates a possible loss of leaktightness in the system. This can be verified with a conventional pressure-holding test. The method and device are characterized by the fact that it is not necessary in principle to interrupt the blood treatment in order to detect a loss of leaktightness.
    Type: Application
    Filed: January 14, 2003
    Publication date: July 24, 2003
    Applicant: Fresenius Medical Care Deutschland GmbH.
    Inventors: Klaus Balschat, Helmuth Ender, Alfred Gagel, Reiner Spickermann
  • Patent number: 6595944
    Abstract: A machine and method for preparing dialysis fluid for a dialysis machine. Fresh water is mixed with one or more dialysis fluid concentrates. The mixture of water and concentrates is conveyed into an equalizing chamber by a proportioning unit at a predetermined flow rate independent of the dialysate flow rate. Metered addition of the concentrates is performed volumetrically and is monitored on the basis of the conductivity of the dialysis fluid, which is measured by conductivity sensors. Because the mixture of water and concentrates is always conveyed at the same flow rate, the composition of the dialysis fluid can be determined with a high accuracy and the proportioning can be performed accurately.
    Type: Grant
    Filed: June 15, 2001
    Date of Patent: July 22, 2003
    Assignee: Fresenius Medical Care Deutschland GmbH
    Inventors: Klaus Balschat, Michael Koch, Elmar Wolter
  • Publication number: 20020088752
    Abstract: A machine and method for preparing dialysis fluid for a dialysis machine. Fresh water is mixed with one or more dialysis fluid concentrates. The mixture of water and concentrates is conveyed into an equalizing chamber by a proportioning unit at a predetermined flow rate independent of the dialysate flow rate. Metered addition of the concentrates is performed volumetrically and is monitored on the basis of the conductivity of the dialysis fluid, which is measured by conductivity sensors. Because the mixture of water and concentrates is always conveyed at the same flow rate, the composition of the dialysis fluid can be determined with a high accuracy and the proportioning can be performed accurately.
    Type: Application
    Filed: June 15, 2001
    Publication date: July 11, 2002
    Inventors: Klaus Balschat, Michael Koch, Elmar Wolter